Vivos Therapeutics, Inc

Contributing Author

Recent Articles by Vivos Therapeutics, Inc

Aug-14	Vivos Therapeutics Reports Second Quarter 2026 Financial Results and Provides Operational Update VVOS +12.45% VVOS -8.77% AH GlobeNewswire
Aug-14	Vivos Therapeutics Schedules Release of Second Quarter 2026 Financial Results and Conference Call VVOS +12.45% GlobeNewswire
Aug-11	Vivos Therapeutics Expands Greenway Health Partnership to Deploy AI-Enabled Platform Across All Clinical and Revenue Operations VVOS GlobeNewswire
Aug-05	Vivos Therapeutics Announces Issuance of New US Patent Broadening Protection for Its Vivos CARE Oral Medical Device Technology VVOS -26.31% GlobeNewswire
Jun-30	Vivos' Vida Appliance Shows Statistically Significant Improvement in Insomnia Severity in 100% of Study Participants VVOS -7.81% GlobeNewswire
Jun-22	Vivos Therapeutics and Streeterville Extend Timeframe of Strategic Financing Agreement and Reaffirm Commitment to Convert Debt Into Common Stock and Perpetual Preferred Equity VVOS -19.56% GlobeNewswire
Jun-11	Vivos Therapeutics Announces Intent to File a Registration Statement for a Proposed Rights Offering VVOS GlobeNewswire
Jun-10	Vivos Therapeutics Announces Key Collaboration Agreement with Multi-Location Florida Cardiology Group to Extend Much Needed Sleep Apnea and Insomnia Diagnosis and Treatment to Cardiovascular Patients VVOS -8.75% GlobeNewswire
Jun-08	Vivos Therapeutics To Participate in the Small Cap Showcase & WTR Insights on June 9, 2026 VVOS VVOS -19.52% GlobeNewswire
Jun-05	Vivos Therapeutics Announces Binding Agreement for Senior Debt-to-Equity Exchange of Up to $4.5 Million from Streeterville Capital to Support Continued Nasdaq Listing VVOS +24.84% GlobeNewswire
May-20	Vivos Therapeutics Reports First Quarter 2026 Financial Results and Provides Operational Update VVOS GlobeNewswire
Apr-15	Vivos Therapeutics Reports Full Year 2025 Financial Results VVOS +8.89% VVOS -25.85% GlobeNewswire
Apr-15	Vivos Therapeutics Schedules Release of Full Year 2025 Financial Results and Conference Call VVOS +8.89% GlobeNewswire
Apr-07	Vivos Therapeutics Completes Private Placement with Existing Private Equity Investor, New Seneca Partners VVOS -5.34% GlobeNewswire
Mar-26	Vivos Therapeutics Reports that Supported Professional Practices Have Achieved 'In-Network' Status Across Multiple Commercial Health Insurers and Medicare in Key Nevada Market VVOS GlobeNewswire
Mar-17	Recent Study Confirms Fundamental Correlation Between Severity of Obstructive Sleep Apnea and Oral Anatomy VVOS GlobeNewswire
Feb-05	Vivos Therapeutics and SoundHealth Announce Collaboration to Expand Access to SoundHealth's Groundbreaking FDA-Cleared Allergy and Sleep Technologies VVOS GlobeNewswire
Jan-20	Vivos Therapeutics Announces Closing of Exercise of Warrants for $4.64 Million Gross Proceeds VVOS VVOS -7.11% GlobeNewswire
Jan-16	Vivos Therapeutics Announces Exercise of Warrants for $4.64 Million Gross Proceeds VVOS GlobeNewswire
Dec-16	Vivos Therapeutics Announces Grand Opening of Affiliated Sleep Center Near Detroit, Michigan VVOS GlobeNewswire
Dec-15	Vivos Therapeutics to Participate in Online Fireside Chat with Water Tower Research on December 16, 2025, at 11 am EST VVOS GlobeNewswire
Nov-19	Vivos Therapeutics Reports Significant Revenue Growth During the Third Quarter 2025 VVOS VVOS -10.17% GlobeNewswire
Nov-19	Vivos Therapeutics Schedules Release of Third Quarter 2025 Financial Results and Conference Call VVOS GlobeNewswire
Sep-30	Vivos Therapeutics Releases Additional Clinical Data Showing Marked Improvement in Pediatric ADHD from Use of Vivos DNA Device VVOS GlobeNewswire
Sep-17	Vivos Therapeutics Announces Landmark Clinical Trial Results in Pediatric Obstructive Sleep Apnea Treatment VVOS GlobeNewswire
Aug-19	Vivos Therapeutics Reports Second Quarter 2025 Financial Results and Provides Operational Update VVOS GlobeNewswire
Aug-19	Vivos Therapeutics Schedules Release of Second Quarter 2025 Financial Results and Conference Call VVOS GlobeNewswire
Jul-30	Vivos Therapeutics Adds to Management Team to Support Expansion and Growth VVOS GlobeNewswire
Jul-01	Vivos Therapeutics Receives Medicare Approval for VidaSleep Oral Appliance VVOS +22.47% GlobeNewswire
Jun-26	New Clinical Trial Data Published Showing Positive Results from Use of Vivos Technology to Treat Obstructive Sleep Apnea in Children VVOS +10.49% GlobeNewswire
Jun-11	Vivos Therapeutics Completes Acquisition of The Sleep Center of Nevada VVOS +5.21% GlobeNewswire
May-15	Vivos Therapeutics Reports First Quarter 2025 Financial Results and Provides Operational Update VVOS VVOS -16.99% GlobeNewswire
May-14	Vivos Therapeutics Schedules Release of First Quarter 2025 Financial Results and Conference Call VVOS GlobeNewswire

Vivos Therapeutics, Inc

Recent Articles by Vivos Therapeutics, Inc

Upgrade your Finviz experience